Global Oral GLP-1 Market Growth (Status and Outlook) 2026-2032

May 2026 | 76 pages | ID: GAC7C40432F6EN
LP Information

Abstracts

The global Oral GLP-1 market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The main driving factors for oral GLP-1 receptor agonists are the following:

Market demand: As the number of diabetic patients continues to increase around the world, the demand for diabetes treatment drugs is also growing. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have high efficacy and good safety, so the market demand is also increasing.

Scientific and technological innovation: With the continuous development of biotechnology, scientists have continued to conduct in-depth research on GLP-1 receptor agonists, and have a deeper understanding of their mechanism of action and pharmacological effects. This provides technical support for the development of oral GLP-1 receptor agonists and promotes the development of this field.

Policy support: Government support and encouragement policies for the pharmaceutical industry provide a good environment for the development and marketing of oral GLP-1 receptor agonists. For example, agencies such as the U.S. Food and Drug Administration (FDA) have provided a fast track for the approval of innovative drugs, accelerating the marketing process of oral GLP-1 receptor agonists.

Capital investment: The research and development of oral GLP-1 receptor agonists requires substantial financial support, including clinical trials, production and marketing. Large pharmaceutical companies and venture capital institutions are increasingly investing in the field of oral GLP-1 receptor agonists, providing funding for the development of this field.

Clinical needs: Traditional diabetes treatment drugs have some side effects and limitations. As a new type of hypoglycemic drug, oral GLP-1 receptor agonists have better tolerance and lower side effects and can meet clinical needs. , improve the treatment effect and quality of life of patients.

LPI (LP Information)' newest research report, the “Oral GLP-1 Industry Forecast” looks at past sales and reviews total world Oral GLP-1 sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral GLP-1 sales for 2026 through 2032. With Oral GLP-1 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral GLP-1 industry.

This Insight Report provides a comprehensive analysis of the global Oral GLP-1 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral GLP-1 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral GLP-1 market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral GLP-1 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral GLP-1.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral GLP-1 market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Sitagliptin
• Saxagliptin
• Alagliptin
• Others

Segmentation by Application:

• Diabetics
• Weight Loss People
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Novo Nordisk
• Pfizer
• AstraZeneca
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral GLP-1 Market Size (2021-2032)
  2.1.2 Oral GLP-1 Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oral GLP-1 by Country/Region (2021, 2025 & 2032)
2.2 Oral GLP-1 Segment by Type
  2.2.1 Sitagliptin
  2.2.2 Saxagliptin
  2.2.3 Alagliptin
  2.2.4 Others
  2.2.5 Oral GLP-1 Market Size by Type
    2.2.5.1 Oral GLP-1 Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Oral GLP-1 Market Size Market Share by Type (2021-2026)
2.3 Oral GLP-1 Segment by Application
  2.3.1 Diabetics
  2.3.2 Weight Loss People
  2.3.3 Others
  2.3.4 Oral GLP-1 Market Size by Application
    2.3.4.1 Oral GLP-1 Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Oral GLP-1 Market Size Market Share by Application (2021-2026)

3 ORAL GLP-1 MARKET SIZE BY PLAYER

3.1 Oral GLP-1 Market Size Market Share by Player
  3.1.1 Global Oral GLP-1 Revenue by Player (2021-2026)
  3.1.2 Global Oral GLP-1 Revenue Market Share by Player (2021-2026)
3.2 Global Oral GLP-1 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL GLP-1 BY REGION

4.1 Oral GLP-1 Market Size by Region (2021-2026)
4.2 Global Oral GLP-1 Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral GLP-1 Market Size Growth (2021-2026)
4.4 APAC Oral GLP-1 Market Size Growth (2021-2026)
4.5 Europe Oral GLP-1 Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral GLP-1 Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oral GLP-1 Market Size by Country (2021-2026)
5.2 Americas Oral GLP-1 Market Size by Type (2021-2026)
5.3 Americas Oral GLP-1 Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral GLP-1 Market Size by Region (2021-2026)
6.2 APAC Oral GLP-1 Market Size by Type (2021-2026)
6.3 APAC Oral GLP-1 Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral GLP-1 Market Size by Country (2021-2026)
7.2 Europe Oral GLP-1 Market Size by Type (2021-2026)
7.3 Europe Oral GLP-1 Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral GLP-1 by Region (2021-2026)
8.2 Middle East & Africa Oral GLP-1 Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral GLP-1 Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL GLP-1 MARKET FORECAST

10.1 Global Oral GLP-1 Forecast by Region (2027-2032)
  10.1.1 Global Oral GLP-1 Forecast by Region (2027-2032)
  10.1.2 Americas Oral GLP-1 Forecast
  10.1.3 APAC Oral GLP-1 Forecast
  10.1.4 Europe Oral GLP-1 Forecast
  10.1.5 Middle East & Africa Oral GLP-1 Forecast
10.2 Americas Oral GLP-1 Forecast by Country (2027-2032)
  10.2.1 United States Market Oral GLP-1 Forecast
  10.2.2 Canada Market Oral GLP-1 Forecast
  10.2.3 Mexico Market Oral GLP-1 Forecast
  10.2.4 Brazil Market Oral GLP-1 Forecast
10.3 APAC Oral GLP-1 Forecast by Region (2027-2032)
  10.3.1 China Oral GLP-1 Market Forecast
  10.3.2 Japan Market Oral GLP-1 Forecast
  10.3.3 Korea Market Oral GLP-1 Forecast
  10.3.4 Southeast Asia Market Oral GLP-1 Forecast
  10.3.5 India Market Oral GLP-1 Forecast
  10.3.6 Australia Market Oral GLP-1 Forecast
10.4 Europe Oral GLP-1 Forecast by Country (2027-2032)
  10.4.1 Germany Market Oral GLP-1 Forecast
  10.4.2 France Market Oral GLP-1 Forecast
  10.4.3 UK Market Oral GLP-1 Forecast
  10.4.4 Italy Market Oral GLP-1 Forecast
  10.4.5 Russia Market Oral GLP-1 Forecast
10.5 Middle East & Africa Oral GLP-1 Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oral GLP-1 Forecast
  10.5.2 South Africa Market Oral GLP-1 Forecast
  10.5.3 Israel Market Oral GLP-1 Forecast
  10.5.4 Turkey Market Oral GLP-1 Forecast
10.6 Global Oral GLP-1 Forecast by Type (2027-2032)
10.7 Global Oral GLP-1 Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oral GLP-1 Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Oral GLP-1 Product Offered
  11.1.3 Eli Lilly Oral GLP-1 Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Novo Nordisk
  11.2.1 Novo Nordisk Company Information
  11.2.2 Novo Nordisk Oral GLP-1 Product Offered
  11.2.3 Novo Nordisk Oral GLP-1 Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Novo Nordisk Main Business Overview
  11.2.5 Novo Nordisk Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Oral GLP-1 Product Offered
  11.3.3 Pfizer Oral GLP-1 Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 AstraZeneca
  11.4.1 AstraZeneca Company Information
  11.4.2 AstraZeneca Oral GLP-1 Product Offered
  11.4.3 AstraZeneca Oral GLP-1 Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 AstraZeneca Main Business Overview
  11.4.5 AstraZeneca Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Oral GLP-1 Product Offered
  11.5.3 Sanofi Oral GLP-1 Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral GLP-1 Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral GLP-1 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sitagliptin
Table 4. Major Players of Saxagliptin
Table 5. Major Players of Alagliptin
Table 6. Major Players of Others
Table 7. Oral GLP-1 Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Oral GLP-1 Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Oral GLP-1 Market Size Market Share by Type (2021-2026)
Table 10. Oral GLP-1 Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Oral GLP-1 Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Oral GLP-1 Market Size Market Share by Application (2021-2026)
Table 13. Global Oral GLP-1 Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Oral GLP-1 Revenue Market Share by Player (2021-2026)
Table 15. Oral GLP-1 Key Players Head office and Products Offered
Table 16. Oral GLP-1 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oral GLP-1 Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Oral GLP-1 Market Size Market Share by Region (2021-2026)
Table 21. Global Oral GLP-1 Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Oral GLP-1 Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Oral GLP-1 Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Oral GLP-1 Market Size Market Share by Country (2021-2026)
Table 25. Americas Oral GLP-1 Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Oral GLP-1 Market Size Market Share by Type (2021-2026)
Table 27. Americas Oral GLP-1 Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Oral GLP-1 Market Size Market Share by Application (2021-2026)
Table 29. APAC Oral GLP-1 Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Oral GLP-1 Market Size Market Share by Region (2021-2026)
Table 31. APAC Oral GLP-1 Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Oral GLP-1 Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Oral GLP-1 Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Oral GLP-1 Market Size Market Share by Country (2021-2026)
Table 35. Europe Oral GLP-1 Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Oral GLP-1 Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oral GLP-1 Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oral GLP-1 Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Oral GLP-1 Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Oral GLP-1
Table 41. Key Market Challenges & Risks of Oral GLP-1
Table 42. Key Industry Trends of Oral GLP-1
Table 43. Global Oral GLP-1 Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Oral GLP-1 Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Oral GLP-1 Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Oral GLP-1 Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Eli Lilly Details, Company Type, Oral GLP-1 Area Served and Its Competitors
Table 48. Eli Lilly Oral GLP-1 Product Offered
Table 49. Eli Lilly Oral GLP-1 Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Eli Lilly Main Business
Table 51. Eli Lilly Latest Developments
Table 52. Novo Nordisk Details, Company Type, Oral GLP-1 Area Served and Its Competitors
Table 53. Novo Nordisk Oral GLP-1 Product Offered
Table 54. Novo Nordisk Oral GLP-1 Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Novo Nordisk Main Business
Table 56. Novo Nordisk Latest Developments
Table 57. Pfizer Details, Company Type, Oral GLP-1 Area Served and Its Competitors
Table 58. Pfizer Oral GLP-1 Product Offered
Table 59. Pfizer Oral GLP-1 Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Pfizer Main Business
Table 61. Pfizer Latest Developments
Table 62. AstraZeneca Details, Company Type, Oral GLP-1 Area Served and Its Competitors
Table 63. AstraZeneca Oral GLP-1 Product Offered
Table 64. AstraZeneca Oral GLP-1 Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. AstraZeneca Main Business
Table 66. AstraZeneca Latest Developments
Table 67. Sanofi Details, Company Type, Oral GLP-1 Area Served and Its Competitors
Table 68. Sanofi Oral GLP-1 Product Offered
Table 69. Sanofi Oral GLP-1 Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Sanofi Main Business
Table 71. Sanofi Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral GLP-1 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral GLP-1 Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral GLP-1 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral GLP-1 Sales Market Share by Country/Region (2025)
Figure 8. Oral GLP-1 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral GLP-1 Market Size Market Share by Type in 2025
Figure 10. Oral GLP-1 in Diabetics
Figure 11. Global Oral GLP-1 Market: Diabetics (2021-2026) & ($ millions)
Figure 12. Oral GLP-1 in Weight Loss People
Figure 13. Global Oral GLP-1 Market: Weight Loss People (2021-2026) & ($ millions)
Figure 14. Oral GLP-1 in Others
Figure 15. Global Oral GLP-1 Market: Others (2021-2026) & ($ millions)
Figure 16. Global Oral GLP-1 Market Size Market Share by Application in 2025
Figure 17. Global Oral GLP-1 Revenue Market Share by Player in 2025
Figure 18. Global Oral GLP-1 Market Size Market Share by Region (2021-2026)
Figure 19. Americas Oral GLP-1 Market Size 2021-2026 ($ millions)
Figure 20. APAC Oral GLP-1 Market Size 2021-2026 ($ millions)
Figure 21. Europe Oral GLP-1 Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Oral GLP-1 Market Size 2021-2026 ($ millions)
Figure 23. Americas Oral GLP-1 Value Market Share by Country in 2025
Figure 24. United States Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Oral GLP-1 Market Size Market Share by Region in 2025
Figure 29. APAC Oral GLP-1 Market Size Market Share by Type (2021-2026)
Figure 30. APAC Oral GLP-1 Market Size Market Share by Application (2021-2026)
Figure 31. China Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 35. India Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Oral GLP-1 Market Size Market Share by Country in 2025
Figure 38. Europe Oral GLP-1 Market Size Market Share by Type (2021-2026)
Figure 39. Europe Oral GLP-1 Market Size Market Share by Application (2021-2026)
Figure 40. Germany Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 41. France Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Oral GLP-1 Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Oral GLP-1 Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Oral GLP-1 Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Oral GLP-1 Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 54. APAC Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 55. Europe Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 57. United States Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 58. Canada Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 59. Mexico Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 60. Brazil Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 61. China Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 62. Japan Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 63. Korea Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 65. India Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 66. Australia Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 67. Germany Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 68. France Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 69. UK Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 70. Italy Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 71. Russia Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 72. Egypt Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 73. South Africa Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 74. Israel Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 75. Turkey Oral GLP-1 Market Size 2027-2032 ($ millions)
Figure 76. Global Oral GLP-1 Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Oral GLP-1 Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Oral GLP-1 Market Size 2027-2032 ($ millions)